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doi:10.1016/j.kjms.2011.06.013Abstract In this prospective randomized clinical trial, we aimed to evaluate the safety and
efficacy of endourethrotomy with holmium:yttrium-aluminium-garnet (HO:YAG) laser and
compare the outcomes with the conventional cold-knife urethrotomy. Fifty-one male patients
with single, iatrogenic, annular strictures of the urethra were randomly divided into two groups;
21 patients who underwent direct-vision endoscopic urethrotomy with Ho:YAG laser (15 W; 1,200
e1,400 mJ; 8e12 Hz) at 12 o’clock position (laser group) and 30 patients who underwent direct-
vision endoscopic urethrotomy with cold-knife incision at 12 o’clock position (cold-knife group).
The results obtained were analyzed and compared at 3 months, 6 months, 9 months, and
12months postoperatively by clinical evaluation, uroflowmetry, and retrograde urethrographies.
Variables were compared among groups using Fisher’s exact and Mann Whitney U tests. There
were no differences between two groups in terms of patient age, preoperative Qmax value, stric-
ture location, and length. Operative time was shorter in laser group (16.4 8.04 minutes) when
compared with cold-knife group (23.8  5.47 minutes) (p< 0.001). Recurrence-free rate at
3 months was similar between two groups (pZ 0.122). However, recurrence-free rates at
6 months, 9 months, and 12 months were significantly higher in laser group when compared with
cold-knife group (p values were 0.045, 0.027, and 0.04, respectively). No intra- or postoperative
complications were encountered. Use of Ho:YAG laser in the management of urethral stricture
disease is a safe and effective method. In addition, it provides shorter operative time and lower
recurrence rate when compared with the conventional technique.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.t of Urology, Faculty of Medicine, Zonguldak Karaelmas University, ABD 67600, Kozlu, Zonguldak,
.com (H. Tokgo¨z).
vier Taiwan LLC. All rights reserved.
Figure 1. Images (A) before and (B) after laser urethrotomy.
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Urethral stricture disease is defined as narrowing of the
urethral lumen because of fibrosis, which occurs in urethral
mucosa and surrounding tissues. The etiology could be
congenital or idiopathic [1]. Scarred tissue formation does
not occur in congenital strictures, therefore, congenital
strictures are accepted as anomalies rather than true
strictures. Urethral stricture disease might also occur as
a result of inflammation. Trauma is another factor that
leads to this clinical entity. On the other hand, posterior
urethral strictures differ from anterior urethral strictures
as they occur generally after partial or complete rupture of
the urethra because of pelvic trauma. Posterior urethral
injuries result after distention and traction type of trauma
[2]. Anterior urethral injuries are usually isolated and
related with horseback riding type of pelvic trauma.
Endoscopic urethrotomy was first introduced in 1973 by
Sachse [3] with the use of a cold-knife technique to incise
those stricture segments. Several techniques are currently
available for minimally invasive treatment of urethral
strictures, including cold-knife incision, electrocautery,
and various types of laser incisions. Incision with the cold
knife does not cause any thermal effect on surrounding
tissues but should create mechanical injury that may lead
to recurrence in long term. Incision with the electrocautery
should cause significant thermal effect on healthy
surrounding tissues resulting in recurrent strictures during
follow-up. Laser treatment modalities have gained popu-
larity in the last two decades. Carbon dioxide, argon,
potassium titanyl phosphate (KTP), neodymium (Nd):yt-
trium-aluminium-garnet (YAG) and holmium (Ho):YAG
lasers have been used in the treatment of urethral stricture
disease. Recently, the Ho:YAG laser became the primary
choice in endourology practice. It is a kind of a pulsed far
infrared ray with a wavelength of 2,100 nm. It shows
superior capabilities in incisions and vaporization with less
thermal effect compared with electrocautery and other
laser types.
In our study, we aimed to evaluate the safety and effi-
cacy of endourethrotomy with Ho:YAG laser. To the best of
our knowledge, this is the first prospective, randomized
clinical trial that compared the outcomes of Ho:YAG laser
urethrotomy with the conventional cold-knife technique.
Materials and methods
The study was approved by our institutional review board.
All the patients gave us a signed, written informed consent
form before performing surgery. A total of 51 male patients
who underwent optic urethrotomy for single, iatrogenic,
annular strictures of the urethra were enrolled in the study.
The patients were randomized into two groups as the
Ho:YAG laser (laser group) and cold-knife groups (cold-knife
group). The randomization was performed by a “random
number table,” allocating 21 men to the laser treatment
group and 30 to the cold-knife treatment group. Laser
group comprised 21 patients who underwent direct-vision
endoscopic urethrotomy with Ho:YAG laser (15 W;
1,200e1,400 mJ; 8e12 Hz) at 12 o’clock position (Fig. 1).
Cold-knife group comprised 30 patients who underwentdirect-vision endoscopic urethrotomy with cold-knife inci-
sion at 12 o’clock position.
All patients were preoperatively evaluated with
following parameters: full personal and family history,
physical examination, routine blood analysis (complete
blood counts and serum biochemical analysis), urine anal-
ysis and culture, uroflowmetric assessment.
Stricture localization and length of the stricture segment
were identified during direct visualization with optical
urethrotome. A 5 French (F) ureteral catheter was used to
measure the length of the stricture segment. In addition,
operative time was recorded. Operative time was described
as the time interval beginning with insertion of optical
urethrotome from external urethral meatus, continuing
with the treatment of stricture site either by laser or cold-
knife, and ending with the removal of urethrotome from
external urethral meatus.
All patients were reevaluated at first month and 3
months, 6 months, 9 months, and 12 months post-
operatively. During follow-up, patients were assessed with
detailed physical examination, urine analysis and culture,
uroflowmetry (repeated if voided volume was <150 mL),
and retrograde urethrography if obstructive symptoms were
developed or maximum flow rate during uroflowmetric
assessment was 10 mL/sec or lower.
The procedure was accepted as successful if the patient
did not report any voiding difficulty, the maximum flow rate
(Qmax) was greater than 10 mL/sec with no or insignificant
residual urine (<100 mL). All patients were catheterized
for 24e48 hours postoperatively (16F silicone urethral
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intravenously 30 minutes before the operation. Post-
operatively, 500 mg cefuroxime axetil (twice a day) was
prescribed for 7 days.
Exclusion criteria were strictures greater than 20 mm in
length, multiple (>1 site), congenital, postradical prosta-
tectomy strictures, or strictures which recurred more than
once (>1 recurrence). Patients who were lost during
follow-up were also excluded from the study.
Surgical technique
All the procedures have been performed by one surgeon (M.
A.). Surgical procedures were performed under general or
regional anesthesia. Patients were placed in a lithotomy
position and stricture sites were examined using a 20F
cystoscope. After the measurement of stricture length via
5F ureteral catheter, a 0.035 in. hydrophilic glide wire was
inserted into the bladder through cystoscope. The cysto-
scope was removed out from urethra leaving the glide wire
inside. Then, with a 22F cystoscope, stricture site was
incised at 12 o’clock position using a 500-u3 fiber at 15 W
laser power (1,200e1,400 mJ and 8e12 Hz frequency)
(Figs. 1 and 2). In patients randomized to cold-knife group,
stricture site was incised at 12 o’clock position using a cold
knife via 21F urethrotome. After complete incision of
stricture site and achieving easy passage of cystoscope or
urethrotome into the bladder, an indwelling 16F silicone
catheter was left in place for 24e48 hours.
Statistics
Statistical analysis was performed using SSPS Version 11.0
(SPSS, Chicago, IL, USA). Numerical variables, such as
demographic data, operative time, and Qmax values, were
assessed by using Mann-Whitney U test. Categorical vari-
ables, such as stricture localization, stricture type (primary/
secondary), recurrence, and recurrence-free rates, were
analyzed by Fisher’s exact test. A p value less than 0.05 was
accepted as statistically significant.
Results
Twenty-one (41%) of 51 cases underwent Ho:YAG laser
urethrotomy (laser group) for urethral stricture disease,Figure 2. Recurrence-free rates for 12 months. Although
statistically insignificant, please note that most recurrences in
cold-knife group were seen during first 3 months postoperatively
[*statistically significant p value (Fisher’s exact test)].whereas 30 (59%) cases underwent classic (cold knife)
internal urethrotomy (cold-knife group). Mean age for the
whole study population was 61.41 12.86 years (range:
24e85 years). Iatrogenic bladder neck contraction after
transurethral resection of the prostate was the etiology for
posterior urethral strictures in all cases. Similarly, for
anterior urethral strictures, causative factor was iatrogenic
reasons (such as history of prolonged or traumatic urethral
catheterization). Stricture site was bulbous urethra in all
patients who had anterior urethral strictures.
There were no statistically significant differences
between two groups in terms of patient age, preoperative
Qmax value, and stricture location and length (Table 1).
However, there was a statistically significant difference
when both groups were compared in terms of stricture type
(pZ 0.043, Fisher’s exact test). Recurrent strictures
(secondary) were greater in laser group (Table 1).
Operative time was shorter in laser group (16.42 8.04
minutes) when comparedwith cold-knife group (23.83 5.47
minutes) (p< 0.001, Mann Whitney U test). Recurrence rates
for the laser and cold-knife groups were 19% and 46.7%,
respectively (Table 1). Recurrence-free rate at 3 months was
similar between two groups (pZ 0.122, Fisher’s exact test).
However, recurrence-free rates at 6 months, 9 months, and
12 months were significantly higher in laser group when
compared with cold-knife group (p values were 0.045, 0.027,
and 0.04, respectively) (Fig. 2).
No statistically significant differences were seen between
two groups when preoperative, postoperative first month,
6-month and 12-month Qmax values were compared (data
not shown).
No intra- or postoperative complications, such as hemor-
rhage, false route, bacteremia, urinary retention, epididy-
mitis, were encountered in any group.Discussion
Currently, laser is one of the most preferred technological
modalities in endoscopic urologic surgery. Less hemorrhage
and shorter hospitalization time are the most important
advantages in laser surgery [4]. Choice of the surgical
technique depends on experience of surgeon and equip-
ment of the hospital. Because of high recurrence risk in
urethral stricture diseases, deciding for the type of surgical
intervention remains a critically important issue for
endourologists. High recurrence rates, reaching up to 80%,
were reported in literature [5]. Those high rates forced
clinicians to alternative treatment methods, such as various
types of laser applications in urethral stricture disease
management. Nd:YAG, KTP, argon, excimer, diode lasers,
and finally Ho:YAG laser have been used in endoscopic
treatment of urethral stricture disease [6e16]. Bloiso et al.
[9] documented 67% recurrence rate with Nd:YAG laser
after 1-year follow-up. However, Perkash [5] and others
reported a 93% success over a follow-up of 28 months by
using contact chisel-crystal fired Nd:YAG laser. Unfortu-
nately, most authors could not reach this high success rate
[12e16].
Kamal [17] treated 22 urethral stricture patients by
using a 400e600 mm diode laser in direct-contact mode.
After a mean follow-up of 26.7 months, no recurrence was
Table 1 Characteristics in study groups and comparability of groups treated
Parameters Laser group (nZ 21) Cold-knife group (nZ 30) p
Age (y) 63.85 7.98 (49e79) 59.70 15.29 (24e85) 0.774a
Primary/secondary (recurrent), n (%) 15 (71.4)/6 (28.6) 28 (93.3)/2 (6.7) 0.043b
Anterior/posterior, n (%) 13 (61.9)/8 (38.1) 20 (66.7)/10 (33.3) 0.477b
Length of stricture segment (mm) 11.09 3.28 (6e18) 12.3 2.98 (10e19) 0.159a
Operative time (min) 16.42 8.04 (7e35) 23.83 5.47 (15e40) <0.001a
Preoperative Qmax value (mL/sec) 4.52 1.98 4.73 1.47 0.449a
Recurrence/no recurrence, n (%) 4 (19)/17 (81) 14 (46.7)/16 (53.3) 0.040b
a Mann-Whitney U test.
b Fisher’s exact test.
QmaxZmaximum flow rate per second.
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tures (primary) (21.4% recurrence rate). However, seven of
the eight cases (87.5%) with a recurrent stricture after
previous internal cold-knife urethrotomy (secondary) had
a recurrence after laser urethrotomy during follow-up
period. As Dr. Kamal [17] emphasized in the article, deep
fibrotic urethral tissue formation, which decreases the
long-term success of the treatment, is more pronounced in
secondary cases. So, it is not surprising to observe signifi-
cantly higher recurrence rates in secondary cases. The
number of secondary strictures in our study was signifi-
cantly higher in laser group (pZ 0.043, Table 1). Despite
this difference, significantly lower recurrence and higher
recurrence-free rates were noticed in laser group when
compared with cold-knife group. Nevertheless, additional
prospective randomized trials with similar primary and
secondary stricture cases would better identify the differ-
ence between the outcomes in laser and conventional
urethrotomy groups.
Development of restenosis after laser applications is
mainly affected by the wavelength, tissue absorption, and
thermal effects of the laser energy. Deepest tissue pene-
tration was demonstrated with Nd:YAG and diode lasers
(4e5 mm). KTP and argon lasers have a 1e3 mm tissue
penetration. Ho:YAG laser has the lowest tissue penetration
(less than 0.5 mm). For any treatment with laser in narrow
luminal organs, such as urethra, selection of laser types
with minimum tissue absorption, such as Ho:YAG, may
decrease scarred tissue reactions over treated area.
Several studies have documented less scarred tissue
formation at incision site with laser surgery when compared
with cold knife or electrocautery [18]. During incision with
a laser in urethral stricture disease, scarred tissue was also
evaporated, so extirpation of the fibrous tissue by direct
contact of the laser fiber could be achieved even when low
power energy was used [10].
In a study by Montorsi et al. [4], Ho:YAG laser was used
for the enucleation of prostate and less hemorrhage,
shorter catheterization time, and hospital stay were
reported with Ho:YAG when compared with transurethral
resection of the prostate. Naturally, similar results should
be expected for treatment of urethral strictures with
Ho:YAG laser. In our trial, no complications were encoun-
tered in any study groups. Therefore, we accepted Ho:YAG
laser as safe and reliable as conventional cold-knife ure-
throtomy. In a study by Kamp et al. [19], 32 male patientswith symptomatic urethral strictures were treated with
Ho:YAG laser urethrotomy at 12 o’clock position. As in our
study, laser energy used in this study was 1,200e1,400 mj.
Although, laser energy was set on a frequency of 10e13 Hz
in the study by Kamp et al. [19], we preferred a lower
frequency, 8e12 Hz, to minimize deep tissue penetration
and coagulation on urethra. This low setting may also have
contributed to the success of treatment by preventing
thermal injury on surrounding healthy tissues, thereby
decreasing reactive fibrous tissue formation. The success
rates were comparable (In the study by Kamp, overall
success rate was 70% after a mean 27-month follow-up
period and in present study, it was 81% after a 12-month
follow-up period).
“Time to recurrence” is also an important parameter in
urethral stricture disease. In the cold-knife group, 8 of 14
(57.1%) recurrences appeared within the first 3 months,
whereas in the laser group, 2 of 4 (50%) recurrences were
demonstrated within the first 3 months. Within the 3e6-
months period during follow-up, one new case in the laser
group and four new cases in the cold-knife group were
diagnosed. Within the 6e9-months period and 9e12
months-period, the number of new recurrent cases were
zero and one for the laser group, and one and one for the
cold-knife group, respectively. So, for our study population,
we can say that the cold-knife treated cases tended to
recur within the first 3 months or 6 months postoperatively
when compared with laser-treated patients.
It is proposed to perform internal urethrotomies
between two corpus cavernosum at 12 o’clock position to
avoid hemorrhage. However, single-site incision is not
enough for some strictures and additional incisions at 6
o’clock position may be necessary. Alternatively, incisions
at 10 o’clock position and 2 o’clock position were also
suggested [20]. Currently, among endourologists, most
popular method is to incise at 12 o’clock position or at the
location where maximal scarred tissue formation occurred
[19]. We performed incisions in both groups at 12 o’clock
position and no corpus cavernosum injury was observed in
any of our patients.
Kamp et al. [19] reported that the stricture site, oper-
ative time, and the duration of catheterization had no
impact on the recurrence of stricture or success of treat-
ment. However, previous urethrotomy and stricture length
were found to be significant risk factors for the recurrence.
In our study, operative time was significantly lower in laser
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group might participate in low recurrence rate observed.
Thus, prevention of prolonged operative time during ure-
throtomy surgery should increase the success of treatment.
Duration of urethral catheterization after endoscopic
incision of urethral strictures is still a controversial issue. In
the literature, this duration ranges from 24 hours up to 6
weeks [5,12,20]. But, postoperatively prolonged urethral
catheterization is accepted as the most important risk
factor for urinary tract infections [21]. Those infections
may result in sepsis, prolonged hospital stay, increased
costs, and mortality. To avoid related complications, we
performed urethral catheterization for a maximum of 48
hours in our study.
In recent years, the choice of prophylactic antibiotics
has gained importance because of increased antimicrobial
resistance among the whole world. Resistance rate to
ciprofloxacin reached up to 20% for Escherichia coli, Pseu-
domonas, and Klebsiella [22]. Kashanian et al. [23] evalu-
ated 10,000 E coli urine cultures and reported a 24%
resistance prevalence for ciprofloxacin. Wagenlehner et al.
[24] found 12% ciprofloxacin resistance even after single
dose of prophylactic ciprofloxacin administration. When
compared with ciprofloxacin, lower rates of cephalosporin
resistance were reported [22]. Therefore, for prophylaxis,
we administered a single dose of cephalosporin 30 minutes
before surgery and continued with oral sefuroxime axetil
postoperatively.
In conclusion, use of Ho:YAG laser in the management
of urethral stricture disease is a safe and effective method.
It also provides shorter operative time and lower recurrence
rate when compared with the conventional technique.
Nevertheless, randomized trials with large series and longer
follow-up period aremandatory to give a discrete conclusion.References
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